Benzoylecgonine (BZE) extraction from urine was explored using Cerex Polycrom Clin II solid-phase extraction (SPE) columns and the Speedisk 48 Pressure Processor as an alternative to the PrepTM1 automated sample processor and XTRX TM Type RP/W columns. Linearity for urine standards extracted using the Cerex.Speedisk method ranged from 20 to 3000 ng/mL. The mean recovery at the lO0-ng/mL cutoff for three lots of columns was 92%. The mean of the within-run means for three batches, which had coefficients of variations of 1.8% or less, was 101.3 ng/mL at the lO0-ng/mL cutoff level. Forty-six specimens known to contain BZE were analyzed by both the Prepl-Type RP/W and Cerex-Speedisk methods. The correlation for specimen BZE concentrations between the two methods gave an r 2 of 0.9999 and a slope of 1.03. The Cerex-Speedisk system is an inexpensive alternative to the Prepl-Type RP/W system. It is less costly, requires little maintenance, has a small footprint, is hood compatible, and can process four times the number of specimens in a given time.
Introduction
In a high-volume forensic drug testing laboratory, labor-saving and high-throughput procedures are essential to meet customer turn around time demands. Confirmation of drugs of abuse in urine specimens is one of the more costly and time consuming processes. Several solid-phase extraction (SPE) procedures, processed either manually or automatically, exist to extract benzoylecgonine (BZE) from urine specimens prior to gas chromatographic-mass spectrometric (GC-MS) analysis (1) (2) (3) (4) (5) . We are currently using the Prep1 and computerized XTRX-4 automated sample processors (Prepl-RP/W method). These processors are costly, require regular maintenance, and have limited sample capacity. In search of a rapid and less costly procedure, we have evaluated the use of Cerex Polycrom Clin II SPE columns processed in a Speedisk 48 Pressure Processor (Cerex-Speedisk method) for the extraction of BZE from urine (6) . The Speedisk processor uses positive pressure to push liquids through the SPE columns. The Cerex columns are packed with a microparticulate cation exchange divinyl-benzene copolymer that functions in both the ion exchange and hydrophobic modes to extract BZE from urine. The copolymer is pH and flow insensitive and does not require preconditioning for urine specimens.
Forty-six military service member specimens known to contain BZE and no longer required to be retained in our laboratory were analyzed simultaneously for BZE by both the Prepl-RP/W method and the Cerex-Speedisk method. Linearity, recovery, precision, and accuracy data from the Cerex-Speedisk method were compared with similar data from the Prepl-RP/W method.
Materials and Methods

Reagents/cartridges
All reagents used were analytical grade or better. The following chemicals were obtained: methanol, isopropanol, isooctane, ethyl acetate, dichloromethane, and dimethyl sulfoxide (Burdick & Jackson, Muskegon, MI); ammonium hydroxide, hydrochloric acid, and sulfuric acid (Mallinckrodt Baker, Inc., Paris, KY); 1-iodobutane and triethylphenylammonium hydroxide (Spectrum Quality Products, Inc., New Brunswick, N J); sodium phosphate monobasic and sodium phosphate dibasic (Fisher Scientific, Fair Lawn, NJ); sodium bicarbonate and sodium azide (Sigma-Aldrich Co., Milwaukee, WI); sodium carbonate (E.M. Science, Gibbstown, N J); and tetramethylammonium hydroxide (Janssen Chemical, Geel, Belgium). The Cerex Polycrom Clin II columns for use in the Speedisk Pressure Processor were purchased from SPEware Corporation (San Pedro, CA). Columns, XTRX Type RP/W, for the Prep1 automated sample processor were purchased from Creative Technology Systems, Inc. (Newark, DE).
Extraction apparatus
The Speedisk 48 Place Pressure Processor was purchased from SPEware Corporation (San Pedro, CA). A TurboVapLV TM purchased from Zymark Corporation (Hopkinton, MA) was used for solvent evaporation. Prep1 automated sample processors were purchased from DuPont Company (Wilmington, DE).
Standards and controls
BZE (1 mg/mL in methanol, lots 32469-49C and 30318-61B) and BZE-d3 (100 pg/mL in methanol, lot SDK-13863-40) standards were purchased from Radian International (Austin, TX). Urine calibrators, standards, and controls were prepared by spiking BZE-negative pooled human urine that contained I g/L sodium azide with the commercial source of BZE. The urine standards and controls were stored in the refrigerator at 4 • 2~ prior to use. The internal standard, BZE-d3, was prepared in methanol.
Processing of samples
Urine samples were processed in batches that contained a 100 ng/rnL BZE calibrator, quality-control samples (QCs) at 40 ng/mL (low), 125 ng/mL (high), and a negative control. The concentration of internal standard, BZE-d3, for all tests was 100 ng/mL. All data presented are for 4-mL urine aliquots unless otherwise specified.
Cerex extraction procedure for BZE
Specimens were processed for extraction by adding 0.8 mL of 500 ng/mL BZE-d3 internal standard in methanol and 2 mL of 0.1M sodium phosphate buffer (pH 6) to 4 mL of urine. The specimens were then vortex mixed and centrifuged, and the supernatant was decanted into Cerex Polycrom Clin II (6 mL, 50 rag) columns. The columns were placed into the Speedisk Pressure Processor and the supernatant passed through the columns at a pressure of 2-5 psi. The columns were washed sequentially with I mL each of water, 0.1N HC1, and methanol at a pressure of 2-3 psi and then dried for 2 min with nitrogen at 25 psi. The BZE was then eluted with 2 mL of dichloromethane/isopropanol/ammonium hydroxide (78:20:2), prepared fresh daily, at a pressure of 1-2 psi or by gravity followed by a pressure pulse. The eluate was evaporated to dryness with air at a temperature of 50-60~ in a Zymark TurboVapLV.
All extracts were derivatized prior to GC-MS analysis using 1-iodobutane, tetramethylammonium hydroxide (TMAH), and triethylphenylammonium hydroxide (TEPAH) according to the modified procedure of Van Minden and D'Amato (7). The residue was dissolved in 100 ~L of solution (TMAH 0.05 mL, TEPAH 1 mL, dimethyl sulfoxide 10 mL) and 5 ~L of 1-iodobutane was added. The mixture was vortex mixed for i rain and then incubated for 15 rain in a water bath at 50 to 60~ After incubation, 1 mL of 0.2N sulfuric acid and I mL of ethyl acetate were added, vortex mixed, and the upper phase aspirated to waste. To the remaining aqueous phase were added I mL of carbonate buffer (pH 9.5) and 2 mL of isooctane. The contents were vortex mixed, the upper phase transferred to a test tube, and the extract evaporated to dryness with air in the TurboVapLV at a temperature of 50 to 60~ The residue was dissolved in 40 I~L of isooctane, and 1-2 IlL was injected into the GC--MS instrument.
The procedure was also tested for the extraction of 2-mL urine aliquots as some applications may require smaller urine volumes. The procedure was the same for the 2-mL urine aliquots except that 0.4 mL of the BZE-d3 internal standard in methanol and 1 mL of 0.1M sodium phosphate buffer (pH 6) were added to the specimen. The specimens were processed using Cerex Polycrom TM Clin II (3 mL, 35 rag) columns.
Prep1 procedure for BZE
Benzoylecgonine was extracted by the Prepl-RP/W method according to the modified procedures of Czarny and Hornbeck (8) and Paul et al. (9) . To 4 mL of urine were added 0.8 mL of 500 ng/mL BZE-d3 internal standard in methanol and 1 mL of 0.1M potassium phosphate buffer (pH 7). The samples were vortex mixed and centrifuged, and the supernatant was decanted into XTRX Type RP/W columns and processed in the Prep1 automated sample processor with mixtures of methanol/water (10:90) in reservoir I and ethyl acetate/methanol (75:25) in reservoir 2. The eluate was transferred from the Prep1 collection cups into 13 x 100-ram test tubes. Both the evaporation of the eluate and the derivative preparation were the same as described in the Cerex procedure.
GC-MS analysis for BZE
A model 5890 series II Hewlett-Packard GC equipped with a G1513A autosampler coupled to a 5972 mass selective detector (MSD) was used for analysis. The instrument was tuned daily using perfluorotributylamine with ions rn/z 69, 219, and 502 monitored for instrument performance. The GC was equipped with an Ultra 2 column (cross-linked 5% PH ME Siloxane), 12. . Specimens were analyzed using a split injection (1:15), an injector temperature of 250~ and an isothermal oven temperature of 240~ which gave a 4-rain retention time (RT) and 5-rain total run time.
The instrument was operated in the SIM mode. Specimens were quantitated using the BZE-d3 internal standard. The ions monitored were rn/z 82, 224, and 345 and m/z 227 and 348 for the butyl derivatives of BZE and the internal standard, respectively. Data acquisition and analysis was performed with HewlettPackard G1701BA ChemStation software in the drug analysis mode. A one-point calibration at 100 ng/mL (Department of Defense cutoff) was obtained from the areas of the 345/348 ions. Benzoylecgonine concentrations (ng/mL) were calculated from this calibration.
For data to be acceptable, the RTs and mass ion ratios (MIRs) had to be within • 2% and + 20%, respectively, of the calibration sample.
Results and Discussion
tinearity
Three batches of 4-mL aliquots and two batches of 2-mL aliquots each containing the following concentrations of BZE were extracted: 10, 20, 25, 30, 40, 100, 125, 500, 1000, 2000, 3000, 4000, and 5000 ng/mL. Linearity curves for each batch were determined from a linear regression which plotted the target value versus the measured value. The linearity range was defined as that concentration range where the slope determined from the regression was in the range of 0.9-1.1 and the correlation coefficient (r 2) 0.99 or greater. Concentrations at 10 ng/mL quantitated within 3-10% of the target value, but the MIRs in two batches of the 4-mL aliquots and both batches of 2-mL aliquots were out of the + 20% range; thus, 20 ng/mL was determined to be the lower limit of linearity. The upper limit of linearity was determined to be 3000 ng/mL for the batches composed of both 4-mL and 2-mL aliquots. Representative linear regression analyses for one batch each of the 4-mL and 2-mL aliquots in the range of 20 to 3000 ng/mL gave slopes of 0.91 (r ~ = 0.9992) and 0.93 (r 2 = 0.9999), respectively. Because the molecular ion, m/z 348, of the internal standard is used as the quantitating ion, there is contribution from the 348 ion in BZE to the 348 ion in the internal standard which causes the lineafity to fall off as the concentration of BZE increases. Linear regressions for BZE concentrations from 20 to 1000 ng/mL for the 4-and 2-mL aliquots gave slopes of 0.98 (r 2 = 0.9997) and 0.96, (r 2 = 0.9999), respectively, whereas for concentrations from 20 to 5000 ng/mL, the slopes were 0.85 (r 2 = 0.9970) and 0.83 (r 2 = 0.9940), respectively. Current and historical linearity data obtained from extracts processed using the Prepl-RP/W method show the same relationship. Figure I shows a representative linearity curve for BZE concentrations over the range of 20 to 3000 ng/mL using the Cerex-Speedisk method.
Precision and accuracy
Between-run precision and accuracy for batches composed of 4-mL aliquots were calculated for seven different BZE concentrations (Table I) . These values were obtained from standards and controls in the batches analyzed for linearity, precision at the cutoff, recovery, and member specimens known to contain BZE.
Accuracy was good for lower concentrations of BZE, but deviated 10% from the target at 3000 ng/mL because of the 0.33% contribution from the 348 ion in BZE to the 348 ion of the BZE-d3 internal standard. Precision and accuracy for the 40-and 125-ng/mL controls between five batches composed of2-mL aliquots gave a mean concentration of 39.6 ng/mL, 4.0% CV and a mean concentration of 123.6 ng/mL, 2.6% CV, respectively. These data are consistent with those determined for the batches consisting of 4-mL aliquots.
Precision and accuracy at the cutoff (100 ng/mL), which is the concentration we use to distinguish a negative specimen from a positive specimen, was determined from three batches each composed of eight 100-ng/mL standards in addition to the calibrator and QCs. Each batch was extracted on different days within the 134-day test period. Data from these batches are given in Table II . There was a 2.9% difference between the highest and lowest means obtained over the test period. The mean of the within-run means for three batches, which had coefficients of variations of 1.8% or less, was 101.3 ng/mL. Precision and accuracy at the cutoff for a batch (n = 8) consisting of 2-mL aliquots gave a mean concentration of 98.5 ng/mL, a CV of 2.01%, and 1.5% accuracy deviation, which is in the same range as that determined for the batches consisting of 4-mL aliquots. Precision and accuracy data for the Cerex-Speedisk method are consistent with batches analyzed using the Prepl-RP/W method.
Precision and accuracy within a batch at the lowest acceptable concentration that consistently met all chromatography and MIR criteria, 20 ng/mL, were determined from extracting one batch composed of six BZE urine standards (4 mL, 20 ng/mL) in addition to the calibrator and QCs. The mean concentration of the six values was 20.23 ng/mL (SD 0.58, CV 2.87%, and accuracy deviation 1.2%).
Recovery
Recovery was determined at three concentrations of BZE by extracting negative urine spiked with BZE at 40, 100, and 3000 ng/mL. At each recovery level, batches containing: a 100-ng/mL calibrator, controls at 40 ng/mL and 125 ng/mL, the recovery level, a negative, and six recovery standards were extracted. Internal standard was added to the calibrator and controls prior to extraction and after extraction to the recovery standards. The derivatives were then prepared for all samples in the batch. A one-point calibration curve was obtained from the calibrator in the batch and the amount of BZE recovered calculated from the curve. Recovery data for 4-mL aliquots determined at the cutoff (100 ng/mL) for three lots of columns and one lot of columns at the three concentrations (40, 100, and 3000 ng/mL) are given in Table III . Mean recovery at the cutoff using 2-mL aliquots (lot 2K1020) was 86.7% (SD 4.6, %CV 5.3) for n = 6. All recoveries were above 86% at the cutoff between lots and within a lot for both the 4-and 2-mL procedures. Recoveries that were determined within a lot at three concentrations were in the upper 80-90% range for the low and cutoff concentrations but there was a drop to 80% at 3000 ng/mL. Recoveries at the cutoff for the Cerex-Speedisk method were comparable to those obtained using the Prepl-RP/W method, which are in the range of 85%.
Analysis of specimens
Forty-six military service member specimens known to contain BZE which were stored frozen at-10 ~ • 2~ for one year and no longer required to be retained in our laboratory were extracted using both the Cerex-Speedisk and the Prepl-RP/W methods. Duplicate batches of specimens (7 or 8 specimens plus 3 QCs and a calibrator) were prepared so that the same specimens were extracted by both methods, derivatized, and analyzed on the same day. Specimens which had concentrations above the upper limit of linearity when they were initially analyzed were diluted prior to analysis in order to prevent the BZE concentrations from exceeding the LOL of 3000 ng/mL. A comparison of BZE concentrations for specimens extracted by both methods showed that 82% of the specimens had differences of less than 3%. The concentration of BZE obtained for all specimens extracted using both the Cerex-Speedisk method and the Prepl-RP/W method agreed within 5%. The correlation for specimen concentration between the two methods gave a slope of 1.03 and a correlation coefficient of 0.9999 (Figure 2) .
After evaporation of the eluate, specimens processed using the Cerex-Speedisk method contained little to no visible residue prior to derivative preparation, but those specimens processed using the Prepl-RP/W method contained an oily brown residue. The BZE and BZE-d3 peaks in the chromatograms from extracts from both methods were resolved from other constituents in the extracts; however, this is probably the result of the additional clean-up during derivative preparation. 
Conclusions
The Prep1 and computerized XTRX-4 automated sample processors are costly, require regular maintenance, and take up considerable floor space as compared with the Speedisk Pressure Processor. The Speedisk Pressure Processor is inexpensive, operates only with a pressure-actuated valve, and fits easily under a ventilation hood. Forty-eight specimens, standards, and controls can be processed simultaneously with the Speedisk processor, whereas the Prep1 and XTRX processors can handle only 12 specimens, standards, and controls at a time. Thus, four times the number of specimens can be processed in the same time using the Speedisk.
Our data demonstrate that the Cerex-Speedisk system is efficient for batches composed of either 2-or 4-mL urine samples. The majority of our data were collected from 4-mL urine aliquots, which is the volume we use for the Prepl-RP/W method in our production runs. Linearity, precision, accuracy, and recovery data obtained from the Cerex-Speedisk method are comparable to that obtained using Prepl-RP/W method. Therefore, the Cerex-Speedisk method is a viable and inexpensive alternative to the Prepl-RP/W method.
